Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Where Is Amarin Really? [View instapost]
    sts66, sNDA acceptance date was to be approx. 74 days from date of submission. It came 2 weeks earlier. Thus it was not on exactly on time. And lets not forget, no Adcom for Anchor. Direct PDUFA.

    100% month to month is also partially correct. Here are parts of the transcript from the cc: '.... On the Vascepa sales side, in the three months since launch, February and March which were part of the first quarter and April part of the second quarter which we can report today, we recorded 3200, 7200, 11,800 prescriptions normalized TRXs approximately. This brings the total number of prescriptions to well over 22,000..' . From launch prescriptions have gone 100% of the initial month every month.
    May 16, 2013. 02:43 AM | Likes Like |Link to Comment
  • Price Target Update For Amarin (AMRN) [View instapost]
    I would'nt say its a pointless study. In fact this study helps Vascepa is more ways than one. It solidifies the fact that OTCs dont work in reducing CV events and so, same priced RX Vascepa with proven results works and is a much better option. This if anything will help in the long run in the ever increasing Vascepa sales. This study has proven why Vascepa is much better option than any other available.
    May 9, 2013. 08:10 AM | 2 Likes Like |Link to Comment